molmir admin– Author –
-
CEO Dr. Mori will pitch at the Demo Day by Rising Biotech Challenge
On November 20, 2024, Plug and Play, a partner of the Tokyo SUTEAM initiative, will hold the final presentation event, Demo Day, for the Biotech accelerator program, Rising Biotech Challenge. Demo Day will be held at Tokyo Innovation Bas... -
molmir was interviewed at the Kansai Startup Night Vol.6 by kr36
36kr, the largest Chinese tech startup media in Japan, interviewed molmir CEO Dr. Mori on July 11st at the Kansai Startup Night held by the Union of Kansai Governments. molmir represented the startups from Nara prefecture. Our ambition t... -
Drug development platformer molmir raised fund to observe inter molecular dynamics
molmir, Inc. (Headquarters: Kashihara City, Nara Prefecture; CEO: Eiichiro Mori; hereinafter referred to as molmir) has raised funds through a seed round by a third-party allotment of new shares, underwritten by funds managed by Real Tec... -
molmir raised funds, aiming to build a new drug discovery platform with the technology of “detecting the molecules dynamics.”
Mormil Co., Ltd. (Location: Kashihara City, Nara Prefecture, CEO: Eiichiro Mori) raised a pre-seed round funds through a third-party allotment of shares with Real Tech Fund operated by Real Tech Holdings (Location: Sumida-ku, Tokyo, Repr... -
About our logo and vision
"molmir" conveys the meaning of observing (Miru in Japanese) the movement of molecules (mol). The logo expresses the movement of molecules, and the rounded design is an image of kindness such as life and peace. For the corporate colors, ...
1